Medicines360 is proud to make an important announcement about LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg
[American Journal of Obstetrics & Gynecology] A prospective assessment of pelvic infection risk following same-day sexually transmitted infection testing and levonorgestrel intrauterine system placement
Please select one of the following:
I am a U.S. healthcare professional
I am not a U.S. healthcare professional
Global Partners: WCG and Population Services International
Read the Press Release announcing the launch of AVIBELA (levonorgestrel-releasing intrauterine system) 52 mg in Madagascar.